← Browse by Condition
Medical Condition

lymphedema

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for lymphedema sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — lymphedema Clinical Trials

How many clinical trials are currently recruiting for lymphedema?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for lymphedema, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for lymphedema?
lymphedema research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a lymphedema clinical trial?
Eligibility criteria for lymphedema trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Universiteit Antwerpen 1 trial
Memorial Sloan Kettering Cancer Center 1 trial
University of Aarhus 1 trial
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 1 trial
Universitaire Ziekenhuizen KU Leuven 1 trial

Recruiting Clinical Trials

NCT07708662
Recruiting
Boosted Compression for Lower Limb Chronic Edema
Enrollment
160 pts
Location
Belgium
Sponsor
Universiteit Antwerpen
View Trial →
NCT06144164 Phase 3
Recruiting
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Enrollment
285 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06325618
Recruiting
Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome
Enrollment
150 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →
NCT07472803
Recruiting
Longitudinal Body Composition Assessment in Breast Cancer Patients
Enrollment
100 pts
Location
Taiwan
Sponsor
Taipei Tzu Chi Hospital, Buddh...
View Trial →
NCT03991897
Recruiting
Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?
Enrollment
81 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
View Trial →
NCT05910411
Recruiting
Inelastic Compression in Edema After Revascularization
Enrollment
20 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06494111 Phase 2
Recruiting
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Enrollment
295 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT01521741
Recruiting
Prospective Screening for Breast Cancer-related Lymphedema
Enrollment
10,000 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →

Related Conditions

chronic edema (1) lymphedema arm (1) lymphedema of upper arm (1) breast cancer (1) breast carcinoma (1) female breast cancer (1) turner syndrome (1) cardiovascular diseases (1) inflammation (1) breast neoplasms (1) body composition (1) sarcopenia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology